Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Mallinckrodt
Johnson and Johnson
Moodys
Baxter

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

Claims for Patent: 7,494,654

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,494,654
Title:Compositions and methods for treating cardiovascular conditions with botulinum toxin
Abstract: The present invention provides for methods of treating cardiovascular diseases in a mammal. The methods include a step of administering an effective amount of a botulinum toxin directly to a blood vessel of a mammal thereby treating a cardiovascular disease.
Inventor(s): Brooks; Gregory F. (Irvine, CA), Donovan; Stephen (Capistrano Beach, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:10/870,603
Patent Claims:1. A method for treating coronary arterial blockage in a mammal the method comprising the steps of (a) administering an effective amount of a botulinum toxin directly to a wall of a blood vessel of a mammal in an area of the coronary arterial blockage (b) allowing the blood vessel to dilate (c) inserting a balloon catheter and a stent coated or impregnated with a botulinum toxin into a femoral artery, (d) passing the balloon catheter and stent to the area of the coronary arterial blockage, (e) inflating the balloon catheter, and (f) expanding the stent to brace open the blood vessel, thereby treating the coronary arterial blockage.

2. The method of claim 1 wherein treating the coronary arterial blockage prevents restenosis.

3. The method of claim 1 wherein the botulinum toxin is selected from the group consisting of botulinum toxin type A, botulinum toxin type B, botulinum toxin type C, botulinum toxin type D, botulinum toxin type E, botulinum toxin type F and botulinum toxin type G, mixtures thereof and combinations thereof.

4. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type A.

5. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type B.

6. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type C.

7. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type D.

8. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type E.

9. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type F.

10. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type G.

Details for Patent 7,494,654

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08   Start Trial Allergan, Inc. (Irvine, CA) 2019-08-10 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
AstraZeneca
Colorcon
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.